Skip to main content
. 2014 May 21;2(3):127–132. doi: 10.12954/PI.14050

Table 1.

Perioperative characteristics

Characteristic High-risk (n=101) Very high-risk (n=53) P-value
Age (yr) 73.2 (71–75) 73.5 (71–75) 0.594
Body mass index (kg/m2) 23.9 (22.2–25.4) 23.6 (21.7–25.3) 0.448
Preoperative PSA (ng/mL) 16.8 (6.3–21.7) 26.3 (8.1–35.3) <0.001
Prostate volume (gm) 38.2 (25.4–47.1) 38.4 (24.6–43.8) 0.928
ASA category 0.501
 1 45 (60) 25 (52)
 2 30 (40) 23 (48)
Neoadjuvant hormone therapy 20 (26) 18 (36) 0.139
Nerve sparing 0.729
 No 13 (19) 6 (17)
 Unilateral 11 (17) 4 (11)
 Bilateral 43 (64) 25 (72)
Lymph node dissection
 Standard 49 (66) 28 (60)
 Extended 25 (33) 19 (41)
Operative time (min) 199.1 (168–219) 200.1 (170–230) 0.917
Estimated blood loss (mL) 284.2 (150–400) 347.4 (200–500) 0.181
Complicationsa) 13 (12) 9 (15) 0.239
 Grade I
  Lymphedema/lymphocele 4 (4) 2 (4)
 Grade II
  Transfusion 1 (1) 1 (2)
 Grade III
  Bladder neck contracture 0 (0) 1 (2)
  Inguinal hernia 6 (6) 4 (8)
  Rectal injury 2 (2) 1 (2)

Values are presented as median (interquartile range) and number (%). PSA, prostate-specific antigen; ASA, American Society of Anesthesiologists.

a)

Complications are categorized by the Clavien-Dindo classification.